Yi-Fang Chuang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi-Fang Chuang has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Chang-Fu Kuo
Center for Artificial Intelligence in Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
8 shared publications - Chun-Chieh Wang
Department of Radiation Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan
7 shared publications - Jun-Te Hsu
Department of General Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan
7 shared publications - Pei-Wei Shueng
Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan
7 shared publications - Po-Jui Chen
Department of Radiation Oncology, Proton and Radiation Therapy Center, Chang Gung Memorial Hospital at Linkou, Linkou, Taiwan
7 shared publications - Wei-Heng Kao
Department of Radiation Oncology, Chang Gung Memorial Hospital, Taoyuan, Taiwan
7 shared publications
Latest Publications
- 29 August 2026
- Published by Elsevier in Psychiatry Research
- Vol. 366, 117426
Parental age and depression in young adults: Revisiting gender differences
- 29 August 2026
- Published by Elsevier in Psychiatry Research
- Vol. 366, 117426
Parental age and depression in young adults: Revisiting gender differences
- 20 July 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 104
Sex- and site-specific trends in cancer incidence and survival among adolescents and young adults in Taiwan, 2003–2020
- 20 July 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 104
Sex- and site-specific trends in cancer incidence and survival among adolescents and young adults in Taiwan, 2003–2020
- Open Access
- 2 July 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (10) , 2303-2312
Nonclassical Monocyte Expansion Is Independently Associated with Anemia Severity in Patients with ESKD
Key Points: Nonclassical monocyte expansion is independently associated with lower hemoglobin in patients on hemodialysis after multivariable adjustment. This monocyte–anemia association is independent of systemic inflammation but linked to altered iron homeostasis markers. The association is the strongest in diabetic patients, suggesting that monocyte profiling may identify nontraditional anemia risk. Background: Anemia remains a major contributor to morbidity and mortality in patients treated by hemodialysis despite current anemia management strategies. Nonclassical monocytes (CD14 + CD16 ++ ), which expand in ESKD and participate in iron recycling through heme scavenging, represent an unexplored link to anemia in this population. Methods: In this two-center, cross-sectional analysis of 408 patients treated by prevalent hemodialysis from the prospective Immunity in End-Stage Renal Disease (iESRD) cohort, monocyte subsets were quantified by multicolor flow cytometry. Associations between nonclassical monocyte percentage (%M3) and hemoglobin were evaluated using Spearman rank correlations and multivariable linear regression adjusted for demographics, dialysis vintage, erythropoietin dose, iron parameters, inflammatory markers, and comorbidities. Results: The mean age was 62±12 years, 57% were male, and 45% had diabetes. Patients in the highest %M3 tertile had lower hemoglobin than those in the lowest tertile (10.6±1.2 versus 11.1±1.6 g/dl; P = 0.01). In multivariable regression, each one-tertile higher %M3 was independently associated with 0.29 g/dl lower hemoglobin ( β =−0.29; 95% confidence interval, −0.43 to −0.15; P < 0.001), and this association persisted after further adjustment for BUN and serum creatinine ( β =−0.31; P < 0.001). The association was not attenuated by adjustment for high-sensitivity C-reactive protein, and %M3 showed no correlation with IL-6 or TNF- α . The association was the strongest among diabetic patients (ρ=−0.27; P < 0.001). Conclusions: Nonclassical monocyte expansion is independently associated with anemia severity in patients treated by hemodialysis through an inflammation-independent pathway involving altered iron homeostasis. Monocyte subset profiling may identify patients at risk of refractory anemia.
- 2 July 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (10) , 2303-2312
Open AccessNonclassical Monocyte Expansion Is Independently Associated with Anemia Severity in Patients with ESKD
Key Points: Nonclassical monocyte expansion is independently associated with lower hemoglobin in patients on hemodialysis after multivariable adjustment. This monocyte–anemia association is independent of systemic inflammation but linked to altered iron homeostasis markers. The association is the strongest in diabetic patients, suggesting that monocyte profiling may identify nontraditional anemia risk. Background: Anemia remains a major contributor to morbidity and mortality in patients treated by hemodialysis despite current anemia management strategies. Nonclassical monocytes (CD14 + CD16 ++ ), which expand in ESKD and participate in iron recycling through heme scavenging, represent an unexplored link to anemia in this population. Methods: In this two-center, cross-sectional analysis of 408 patients treated by prevalent hemodialysis from the prospective Immunity in End-Stage Renal Disease (iESRD) cohort, monocyte subsets were quantified by multicolor flow cytometry. Associations between nonclassical monocyte percentage (%M3) and hemoglobin were evaluated using Spearman rank correlations and multivariable linear regression adjusted for demographics, dialysis vintage, erythropoietin dose, iron parameters, inflammatory markers, and comorbidities. Results: The mean age was 62±12 years, 57% were male, and 45% had diabetes. Patients in the highest %M3 tertile had lower hemoglobin than those in the lowest tertile (10.6±1.2 versus 11.1±1.6 g/dl; P = 0.01). In multivariable regression, each one-tertile higher %M3 was independently associated with 0.29 g/dl lower hemoglobin ( β =−0.29; 95% confidence interval, −0.43 to −0.15; P < 0.001), and this association persisted after further adjustment for BUN and serum creatinine ( β =−0.31; P < 0.001). The association was not attenuated by adjustment for high-sensitivity C-reactive protein, and %M3 showed no correlation with IL-6 or TNF- α . The association was the strongest among diabetic patients (ρ=−0.27; P < 0.001). Conclusions: Nonclassical monocyte expansion is independently associated with anemia severity in patients treated by hemodialysis through an inflammation-independent pathway involving altered iron homeostasis. Monocyte subset profiling may identify patients at risk of refractory anemia.
- 30 December 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (4) , 1590-1602
Anti-herpetic treatment reduces dementia risk: A systematic review and meta-analysis
Background: Human herpesvirus (HHV) infections, particularly for herpes simplex virus (HSV) and varicella-zoster virus (VZV), may increase dementia risk, yet the protective effects of anti-herpetic medications remained unclear. Objective: This systematic review and meta-analysis of observational studies aimed to examine the association between anti-herpetic medications and dementia, focusing on HSV or VZV-related infections. Methods: This study followed PRISMA guidelines (CRD42022368318). Cohort or nested case-control studies published from databases’ inception to December 2024 were systematically searched in PubMed, MEDLINE, Embase, Cochrane Library, PsycINFO, and Web of Science. Eligible studies evaluated anti-herpetic medications (e.g., acyclovir, famciclovir, ganciclovir, valacyclovir, valganciclovir) and dementia risk in non-demented adults aged ≥50. Pooled adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) were analyzed using random-effects models. Subgroup and meta-regression analyses were performed to explore potential sources of heterogeneity and effect modifiers. Results: Fourteen cohort studies involving more than 10 million older adults were included. To demonstrate the effects of anti-herpetic medications in various clinical scenarios, the meta-analysis compared: diagnosed and treated versus diagnosed but untreated (aHR=0.77, 95% CI: 0.67–0.89); treated versus untreated regardless of diagnosis (aHR=0.90, 95% CI: 0.87–0.94); and diagnosed and treated versus neither diagnosed nor treated (aHR=0.87, 95% CI: 0.78–0.97). Subgroup analysis and meta-regression identified infection severity as a significant modifier ( p < 0.0001), explaining 89.01% of heterogeneity. Conclusions: This systematic review and meta-analysis reveals notable protective effect of anti-herpetic medication usage on dementia, and the effect is especially pronounced in patients with severe alpha herpesvirus infections.
- 30 December 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (4) , 1590-1602
Anti-herpetic treatment reduces dementia risk: A systematic review and meta-analysis
Background: Human herpesvirus (HHV) infections, particularly for herpes simplex virus (HSV) and varicella-zoster virus (VZV), may increase dementia risk, yet the protective effects of anti-herpetic medications remained unclear. Objective: This systematic review and meta-analysis of observational studies aimed to examine the association between anti-herpetic medications and dementia, focusing on HSV or VZV-related infections. Methods: This study followed PRISMA guidelines (CRD42022368318). Cohort or nested case-control studies published from databases’ inception to December 2024 were systematically searched in PubMed, MEDLINE, Embase, Cochrane Library, PsycINFO, and Web of Science. Eligible studies evaluated anti-herpetic medications (e.g., acyclovir, famciclovir, ganciclovir, valacyclovir, valganciclovir) and dementia risk in non-demented adults aged ≥50. Pooled adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) were analyzed using random-effects models. Subgroup and meta-regression analyses were performed to explore potential sources of heterogeneity and effect modifiers. Results: Fourteen cohort studies involving more than 10 million older adults were included. To demonstrate the effects of anti-herpetic medications in various clinical scenarios, the meta-analysis compared: diagnosed and treated versus diagnosed but untreated (aHR=0.77, 95% CI: 0.67–0.89); treated versus untreated regardless of diagnosis (aHR=0.90, 95% CI: 0.87–0.94); and diagnosed and treated versus neither diagnosed nor treated (aHR=0.87, 95% CI: 0.78–0.97). Subgroup analysis and meta-regression identified infection severity as a significant modifier ( p < 0.0001), explaining 89.01% of heterogeneity. Conclusions: This systematic review and meta-analysis reveals notable protective effect of anti-herpetic medication usage on dementia, and the effect is especially pronounced in patients with severe alpha herpesvirus infections.
- Open Access
- 29 July 2025
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 79 (10) , 677-684
Frailty subtypes and white matter alterations in older adults without dementia
Aim: Frailty increases the risk of cognitive decline in older adults, yet the brain structural patterns associated with different frailty subtypes remain unclear. This study examined white matter (WM) alterations across frailty subtypes in community‐dwelling older adults without dementia.Methods: This cross‐sectional study included participants from the Taiwan Precision Medicine Initiative on Cognitive Impairment and Dementia (TPMIC) cohort. Frailty was assessed using Fried's phenotype and classified into mobility, non‐mobility, and low physical activity subtypes. Cognitive function (attention, memory, and executive function) was evaluated using standardized neuropsychological tests. WM microstructure was measured using diffusion tensor imaging (DTI) metrics, including fractional anisotropy (FA) and mean diffusivity (MD).Results: Among 297 participants, 91 (30.6%) were pre‐frail/frail. The pre‐frail/frail group showed widespread WM alterations, with the internal capsule (IC) remaining significant after full adjustment and FDR correction (q < 0.05). The mobility subtype was associated with poorer cognitive performance across all domains (all P < 0.01) and showed lower FA and higher MD primarily in motor and cognitive‐related tracts, such as the corpus callosum (all q < 0.05). In contrast, the non‐mobility subtype was associated with poorer attention and executive function, with alterations primarily in emotion‐regulation tracts, such as the cingulum and forceps major (all q < 0.05). No significant WM differences were found for the low physical activity subtype.Conclusion: Frailty subtypes are associated with distinct WM alteration patterns, reflecting potentially different mechanisms of brain aging. These findings highlight the importance of subtype‐specific approaches to early detection and intervention.
- 29 July 2025
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 79 (10) , 677-684
Open AccessFrailty subtypes and white matter alterations in older adults without dementia
Aim: Frailty increases the risk of cognitive decline in older adults, yet the brain structural patterns associated with different frailty subtypes remain unclear. This study examined white matter (WM) alterations across frailty subtypes in community‐dwelling older adults without dementia.Methods: This cross‐sectional study included participants from the Taiwan Precision Medicine Initiative on Cognitive Impairment and Dementia (TPMIC) cohort. Frailty was assessed using Fried's phenotype and classified into mobility, non‐mobility, and low physical activity subtypes. Cognitive function (attention, memory, and executive function) was evaluated using standardized neuropsychological tests. WM microstructure was measured using diffusion tensor imaging (DTI) metrics, including fractional anisotropy (FA) and mean diffusivity (MD).Results: Among 297 participants, 91 (30.6%) were pre‐frail/frail. The pre‐frail/frail group showed widespread WM alterations, with the internal capsule (IC) remaining significant after full adjustment and FDR correction (q < 0.05). The mobility subtype was associated with poorer cognitive performance across all domains (all P < 0.01) and showed lower FA and higher MD primarily in motor and cognitive‐related tracts, such as the corpus callosum (all q < 0.05). In contrast, the non‐mobility subtype was associated with poorer attention and executive function, with alterations primarily in emotion‐regulation tracts, such as the cingulum and forceps major (all q < 0.05). No significant WM differences were found for the low physical activity subtype.Conclusion: Frailty subtypes are associated with distinct WM alteration patterns, reflecting potentially different mechanisms of brain aging. These findings highlight the importance of subtype‐specific approaches to early detection and intervention.
- Open Access
- 1 June 2025
- Published by Korean Society of Medical Education in Korean Journal of Medical Education
- Vol. 37 (2) , 153-161
Medical student selection interviews: insights into nonverbal observable communications: a cross-sectional study
Purpose: Interviews play a crucial role in the medical school selection process, although little is known about interviewers’ non-verbal observable communications (NoVOC) during the interviews. This study investigates how interviewers perceive NoVOC exhibited by interviewees in two medical schools, one in Taiwan and the other in Australia. The study also explores potential cross-cultural differences in these perceptions.Methods: A 26-item questionnaire was developed using a Delphi-like method to identify NoVOC. Interviewers from the University of New South Wales, Australia, and National Yang Ming Chiao Tung University, Taiwan (n=47 and N=78, respectively) rated these NoVOC between 2018 and 2021. Factor analyses identified and validated underlying factors. Measurement invariance across countries and genders was examined.Results: A total of 125 interviewers completed the questionnaire, including 78 from Taiwan and 47 from Australia. Using exploratory factor analysis, 14 items yielded reliable three factors “charming,” “disengaged,” and “anxious” (Cronbach’s α=0.853, 0.714, and 0.628, respectively). The measurement invariance analysis indicated that the factor models were invariant across genders but significantly different between the two countries. Further analysis revealed inconsistencies in interpreting the “anxious” factor between Taiwan and Australia.Conclusion: The three distinct factors revealed in this study provide valuable insights into the NoVOC that interviewers perceive and evaluate during the interview process. The findings highlight the importance of considering non-verbal communication in selecting medical students and emphasize the need for training and awareness among interviewers. Understanding the impact of non-verbal behaviors can improve selection processes to mitigate bias and enhance the fairness and reliability of medical student selection.
- 1 June 2025
- Published by Korean Society of Medical Education in Korean Journal of Medical Education
- Vol. 37 (2) , 153-161
Open AccessMedical student selection interviews: insights into nonverbal observable communications: a cross-sectional study
Purpose: Interviews play a crucial role in the medical school selection process, although little is known about interviewers’ non-verbal observable communications (NoVOC) during the interviews. This study investigates how interviewers perceive NoVOC exhibited by interviewees in two medical schools, one in Taiwan and the other in Australia. The study also explores potential cross-cultural differences in these perceptions.Methods: A 26-item questionnaire was developed using a Delphi-like method to identify NoVOC. Interviewers from the University of New South Wales, Australia, and National Yang Ming Chiao Tung University, Taiwan (n=47 and N=78, respectively) rated these NoVOC between 2018 and 2021. Factor analyses identified and validated underlying factors. Measurement invariance across countries and genders was examined.Results: A total of 125 interviewers completed the questionnaire, including 78 from Taiwan and 47 from Australia. Using exploratory factor analysis, 14 items yielded reliable three factors “charming,” “disengaged,” and “anxious” (Cronbach’s α=0.853, 0.714, and 0.628, respectively). The measurement invariance analysis indicated that the factor models were invariant across genders but significantly different between the two countries. Further analysis revealed inconsistencies in interpreting the “anxious” factor between Taiwan and Australia.Conclusion: The three distinct factors revealed in this study provide valuable insights into the NoVOC that interviewers perceive and evaluate during the interview process. The findings highlight the importance of considering non-verbal communication in selecting medical students and emphasize the need for training and awareness among interviewers. Understanding the impact of non-verbal behaviors can improve selection processes to mitigate bias and enhance the fairness and reliability of medical student selection.
- Top Cited PapersOpen Access
- 30 May 2025
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 17 (1) , 1-18
Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer’s disease pathology
Emerging evidence highlights the bidirectional communication between the gut microbiota and the brain, suggesting a potential role for gut dysbiosis in Alzheimer’s disease (AD) pathology and cognitive decline. Existing literature on gut microbiota lacks species-level insights. This study investigates gut microbiota alterations in mild cognitive impairment (MCI), focusing on their association with comprehensive AD biomarkers, including amyloid burden, tau pathology, neurodegeneration, and cognitive performance. We analyzed fecal samples from 119 individuals with MCI and 320 cognitively normal controls enrolled in the Taiwan Precision Medicine Initiative on Cognitive Impairment and Dementia cohort. Shotgun metagenomic sequencing was conducted with taxonomic profiling using MetaPhlAn4. Amyloid burden and plasma pTau181 were quantified via PET imaging and Simoa assays, respectively, while APOE genotyping was performed using TaqMan assays. Microbial diversity, differential abundance analysis, and correlation mapping with neuropsychological and neuroimaging measures were conducted to identify gut microbiota species signatures associated with MCI and AD biomarkers. We identified 59 key microbial species linked to MCI and AD biomarkers. Notably, species within the same genera, such as Bacteroides and Ruminococcus, showed opposing effects, while Akkermansia muciniphila correlated with reduced amyloid burden, suggesting a protective role. Functional profiling revealed microbial pathways contributing to energy metabolism and neuroinflammation, mediating the relationship between gut microbes and brain health. Co-occurrence network analyses demonstrated complex microbial interactions, indicating that the collective influence of gut microbiota on neurodegeneration. Our findings challenge genus-level microbiome analyses, revealing species-specific modulators of AD pathology. This study highlights gut microbial activity as a potential therapeutic target to mitigate cognitive decline and neurodegeneration.
- 30 May 2025
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 17 (1) , 1-18
Top Cited PapersOpen AccessCompositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer’s disease pathology
Emerging evidence highlights the bidirectional communication between the gut microbiota and the brain, suggesting a potential role for gut dysbiosis in Alzheimer’s disease (AD) pathology and cognitive decline. Existing literature on gut microbiota lacks species-level insights. This study investigates gut microbiota alterations in mild cognitive impairment (MCI), focusing on their association with comprehensive AD biomarkers, including amyloid burden, tau pathology, neurodegeneration, and cognitive performance. We analyzed fecal samples from 119 individuals with MCI and 320 cognitively normal controls enrolled in the Taiwan Precision Medicine Initiative on Cognitive Impairment and Dementia cohort. Shotgun metagenomic sequencing was conducted with taxonomic profiling using MetaPhlAn4. Amyloid burden and plasma pTau181 were quantified via PET imaging and Simoa assays, respectively, while APOE genotyping was performed using TaqMan assays. Microbial diversity, differential abundance analysis, and correlation mapping with neuropsychological and neuroimaging measures were conducted to identify gut microbiota species signatures associated with MCI and AD biomarkers. We identified 59 key microbial species linked to MCI and AD biomarkers. Notably, species within the same genera, such as Bacteroides and Ruminococcus, showed opposing effects, while Akkermansia muciniphila correlated with reduced amyloid burden, suggesting a protective role. Functional profiling revealed microbial pathways contributing to energy metabolism and neuroinflammation, mediating the relationship between gut microbes and brain health. Co-occurrence network analyses demonstrated complex microbial interactions, indicating that the collective influence of gut microbiota on neurodegeneration. Our findings challenge genus-level microbiome analyses, revealing species-specific modulators of AD pathology. This study highlights gut microbial activity as a potential therapeutic target to mitigate cognitive decline and neurodegeneration.
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in Taiwanese Journal of Psychiatry
- Vol. 39 (2) , 123-128
The Impact of COVID-19 Pandemic Level 3 Alert on the Incidence of Anxiety and Mood Disorder in Taiwan: An Interrupted Time Series Analysis
Objective: In this study, we intended to evaluate the impact of Taiwan’s COVID-19 pandemic Level 3 alert on anxiety and mood disorders, focusing on age and gender differences. We hypothesized that individuals aged 43+ years, who experienced the 2003 SARS epidemic during their working years, would show increased vulnerability for anxiety and mood disorder. Methods: Using Taiwan’s National Health Insurance data (2018–2021), we did an interrupted time series analysis to compare weekly mental disorder incidence before and after the COVID-19 pandemic Level 3 alert, stratified by age and gender. Results: The overall incidence did not increase, but individuals aged 43+ years were more affected: men showed a sustained, significant increase in the incidence of anxiety disorders (+0.05/100,000 person-days/week, p < 0.01), while women showed significantly more immediate responses (+1.16/100,000 person-days, p < 0.01). Conclusion: These findings highlight the lingering psychological impact of previous health crises and emphasize the need for tailored mental health interventions for high-risk groups during future pandemics or similar events.
- 1 April 2025
- Published by Wolters Kluwer Health in Taiwanese Journal of Psychiatry
- Vol. 39 (2) , 123-128
Open AccessThe Impact of COVID-19 Pandemic Level 3 Alert on the Incidence of Anxiety and Mood Disorder in Taiwan: An Interrupted Time Series Analysis
Objective: In this study, we intended to evaluate the impact of Taiwan’s COVID-19 pandemic Level 3 alert on anxiety and mood disorders, focusing on age and gender differences. We hypothesized that individuals aged 43+ years, who experienced the 2003 SARS epidemic during their working years, would show increased vulnerability for anxiety and mood disorder. Methods: Using Taiwan’s National Health Insurance data (2018–2021), we did an interrupted time series analysis to compare weekly mental disorder incidence before and after the COVID-19 pandemic Level 3 alert, stratified by age and gender. Results: The overall incidence did not increase, but individuals aged 43+ years were more affected: men showed a sustained, significant increase in the incidence of anxiety disorders (+0.05/100,000 person-days/week, p < 0.01), while women showed significantly more immediate responses (+1.16/100,000 person-days, p < 0.01). Conclusion: These findings highlight the lingering psychological impact of previous health crises and emphasize the need for tailored mental health interventions for high-risk groups during future pandemics or similar events.
- Open Access
- 22 February 2025
- Published by Oxford University Press (OUP) in Innovation in Aging
- Vol. 9 (4) , igaf009
Types of Social Group Participation and Long-Term Cognitive Preservation in Older Ages
Background and Objectives: Participating in social groups predicts better cognitive preservation in older adults in the short term (<5 years). Long-term evidence with direct comparison between specific types of social groups is needed. Research Design and Methods: In the Taiwan Longitudinal Study of Aging (n = 4,009, mean age 64 years), 1,479 individuals reported participation in at least 1 of the 4 common types of social groups at baseline in 2003, including socializing, volunteering, religious, and networking groups. Cognitive function was measured by a modified Short Portable Mental Status Questionnaire at years 0 (baseline), 4, 8, and 12. Linear mixed-effects models were used to estimate relative cognitive preservation (in %) compared with individuals who did not participate in social groups at baseline or compared with individuals who participated in different social groups at baseline. Results: We found volunteering group participation was associated with most consistent cognitive preservation at year 4 (35%, 95% CI: +10% to +60%), 8 (+64%, +44% to +84%), and 12 (+57%, +24% to +89%) compared with the individuals who did not participate in social groups, and at year 12 compared with participants of other social groups (+65%, +16% to +114%). Discussion and Implications: Our findings support a long-term prediction of better cognitive preservation among volunteering group participants.
- 22 February 2025
- Published by Oxford University Press (OUP) in Innovation in Aging
- Vol. 9 (4) , igaf009
Open AccessTypes of Social Group Participation and Long-Term Cognitive Preservation in Older Ages
Background and Objectives: Participating in social groups predicts better cognitive preservation in older adults in the short term (<5 years). Long-term evidence with direct comparison between specific types of social groups is needed. Research Design and Methods: In the Taiwan Longitudinal Study of Aging (n = 4,009, mean age 64 years), 1,479 individuals reported participation in at least 1 of the 4 common types of social groups at baseline in 2003, including socializing, volunteering, religious, and networking groups. Cognitive function was measured by a modified Short Portable Mental Status Questionnaire at years 0 (baseline), 4, 8, and 12. Linear mixed-effects models were used to estimate relative cognitive preservation (in %) compared with individuals who did not participate in social groups at baseline or compared with individuals who participated in different social groups at baseline. Results: We found volunteering group participation was associated with most consistent cognitive preservation at year 4 (35%, 95% CI: +10% to +60%), 8 (+64%, +44% to +84%), and 12 (+57%, +24% to +89%) compared with the individuals who did not participate in social groups, and at year 12 compared with participants of other social groups (+65%, +16% to +114%). Discussion and Implications: Our findings support a long-term prediction of better cognitive preservation among volunteering group participants.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Adverse Birth and Obstetric Outcomes in the Offspring of Male Adolescent and Young Adult Cancer Survivors: A Nationwide Population-Based Study
Supplementary Table 1: Disease codes of cancer and comorbid conditions as per the International Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) Revisions, and list of high-risk medications
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Adverse Birth and Obstetric Outcomes in the Offspring of Male Adolescent and Young Adult Cancer Survivors: A Nationwide Population-Based Study
Supplementary Table 1: Disease codes of cancer and comorbid conditions as per the International Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) Revisions, and list of high-risk medications